Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Fecestransplantatie bij ‘C. difficile’ mogelijk met orale capsules
dec 2017 | Bacteriële infecties